The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

GenesisM’s enhanced core platform is designed to provide long-term operational flexibility and accelerate buildout timeline.

In multiple experiments, C-a16 lipids, which contain a phenol group, outperformed LNPs used in currently available mRNA ...

David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the human proteome.

Chemify has opened its first fully automated facility that marries chemistry, AI, computation, and robotics near the school in the city’s Maryhill area—with plans for a second in the US and ...

Thermo Fisher will expand use of the Sanofi site to meet the demand from pharma and biotech customers for U.S. manufacturing capacity.

Using machine learning, OmicsTweezer merges diverse data by using deep learning combined with optimal transport.

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...

Eight babies, born following Mitochondrial Donation treatment to reduce transmission of mitochondrial DNA disease, show no ...

ImP administration to mouse model induced atherosclerosis without altering the lipid profile, and was associated with immune ...